IRIS
AVERSA, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.422
AS - Asia 10.921
EU - Europa 6.514
SA - Sud America 1.531
AF - Africa 523
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 30.938
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.046
SG - Singapore 4.789
CN - Cina 3.492
IE - Irlanda 1.489
BR - Brasile 1.237
HK - Hong Kong 916
SE - Svezia 913
FI - Finlandia 900
IT - Italia 874
DE - Germania 751
TR - Turchia 677
VN - Vietnam 511
UA - Ucraina 428
NL - Olanda 398
ZA - Sudafrica 395
CA - Canada 273
RU - Federazione Russa 174
GB - Regno Unito 158
AR - Argentina 125
FR - Francia 110
BD - Bangladesh 97
IN - India 83
AT - Austria 67
IQ - Iraq 57
JP - Giappone 57
MX - Messico 57
PL - Polonia 55
EC - Ecuador 46
BE - Belgio 44
ES - Italia 36
ID - Indonesia 31
UZ - Uzbekistan 30
CI - Costa d'Avorio 29
CO - Colombia 28
VE - Venezuela 28
PK - Pakistan 25
CZ - Repubblica Ceca 23
KR - Corea 23
PY - Paraguay 23
EU - Europa 22
MA - Marocco 21
RO - Romania 20
LT - Lituania 18
EG - Egitto 16
SA - Arabia Saudita 16
JO - Giordania 12
KE - Kenya 12
CL - Cile 11
IL - Israele 11
PE - Perù 11
DZ - Algeria 10
NP - Nepal 10
OM - Oman 10
BO - Bolivia 9
PA - Panama 9
SN - Senegal 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
IR - Iran 7
UY - Uruguay 7
AL - Albania 6
AZ - Azerbaigian 6
BG - Bulgaria 6
JM - Giamaica 6
TW - Taiwan 6
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
KZ - Kazakistan 5
QA - Qatar 5
TN - Tunisia 5
BY - Bielorussia 4
CH - Svizzera 4
GA - Gabon 4
GY - Guiana 4
HN - Honduras 4
KH - Cambogia 4
NG - Nigeria 4
PS - Palestinian Territory 4
PT - Portogallo 4
SI - Slovenia 4
AM - Armenia 3
AO - Angola 3
AU - Australia 3
BH - Bahrain 3
BN - Brunei Darussalam 3
CM - Camerun 3
DK - Danimarca 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
MY - Malesia 3
NI - Nicaragua 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CG - Congo 2
CY - Cipro 2
Totale 30.903
Salva come PNG Salva come JPEG
Città #
Singapore 2.331
Dublin 1.489
Chandler 1.468
Ashburn 1.135
Beijing 993
Hong Kong 908
Jacksonville 905
Izmir 622
Santa Clara 507
Dallas 497
Nanjing 480
Boardman 423
Dearborn 382
Johannesburg 374
Princeton 352
San Mateo 330
Parma 302
Ann Arbor 236
Wilmington 235
Columbus 234
New York 223
Ho Chi Minh City 213
Los Angeles 189
Toronto 181
Helsinki 155
Shenyang 154
Shanghai 149
Kunming 144
Nanchang 141
Moscow 135
The Dalles 133
Hebei 115
Council Bluffs 110
Hanoi 104
São Paulo 101
Jinan 99
Munich 97
Hefei 96
Des Moines 92
Changsha 91
Tianjin 86
Jiaxing 80
Buffalo 74
San Jose 74
Düsseldorf 59
Guangzhou 55
Vienna 54
Tokyo 50
Milan 48
Norwalk 46
Seattle 43
Turku 42
San Francisco 41
Warsaw 39
Brussels 36
Rome 36
Brooklyn 35
Hangzhou 35
Bologna 34
Rio de Janeiro 34
Montreal 32
Boston 31
Chicago 31
London 31
Zhengzhou 31
Belo Horizonte 30
Frankfurt am Main 29
Kocaeli 29
Abidjan 28
Tashkent 28
Woodbridge 28
Chengdu 27
Marseille 27
Brasília 26
Haiphong 26
Stockholm 26
Falls Church 24
Jakarta 24
Bremen 23
Chennai 23
Seoul 23
Atlanta 21
Houston 21
Mestre 21
Denver 20
Fremont 20
Haikou 20
Wuhan 20
Campinas 18
Guarulhos 18
Phoenix 18
Curitiba 17
Da Nang 17
Dhaka 17
Orem 17
Porto Alegre 17
Biên Hòa 16
Brno 15
Focsani 15
Hải Dương 15
Totale 18.846
Salva come PNG Salva come JPEG
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 217
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 195
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 182
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 179
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 173
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 173
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 169
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. 165
The Proteasome and Myeloma-Associated Bone Disease 164
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 162
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 160
Sindrome preleucemica 159
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 158
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 157
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 157
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 155
The -2518 A/G single nucleotide polymorphism of MCP-1 in myelofibrosis: functional characterization on ex-vivo patient cells. 151
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 147
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 147
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 145
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients 142
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 141
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 141
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 141
''Designed'' grafts for HLA-haploidentical stem cell transplantation 140
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 139
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 138
[Evaluation of the immunological status of patients with Hodgkin's disease] 137
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 136
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 136
A prospective survey of febrile events in hematological malignancies 135
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 135
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 134
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 134
PROTEIN KINASE Ce EXPRESSION IN PRIMARY MYELOFIBROSIS PLATELETS CORRELATES WITH CARDIOVASCULAR EVENTS 134
Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation? 132
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 132
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 132
Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. 130
Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk 130
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 130
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 130
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia. 129
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 129
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 128
[Sequential polychemotherapeutic treatment of inoperable bronchogenic carcinoma] 127
ERK1/2 is the signaling pathway primarily activated in myeloid neoplasms carrying t(8;9)/PCM1-JAK2 fusion. A two cases report. 126
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 126
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 124
Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. 123
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 123
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. 121
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 121
The osteoblastic niche in the context of multiple myeloma 120
Acute lymphoblastic leukaemia in Noonan syndrome. 118
Serie granulocitaria 117
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 117
Allogeneic Hematopoietic stem cell transplantation and natural killer cell alloreactivity, 116
Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors 116
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients. 116
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 114
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 113
The anti-myeloma effect of Lenalidomide is increased by hypoxia-inducible factor (HIF)-1a inhibition in multiple myeloma cells both in vitro and in vivo 113
Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi 113
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry 112
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 112
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 112
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. 110
T cell depleted haploidentical transplantation: positive selection. 110
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide 110
Allogeneic transplantation across the HLA barriers. 108
TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 108
Amiloidosi 107
BORTEZOMIB WITH HIGH DOSE MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND IMPROVES THE RESPONSE RATE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA 107
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 107
Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. 106
T cell depleted HLA-identical bone marrow transplants 106
The haploidentical option for high-risk haematological malignancies. 106
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. 106
Human thrombopoiesis depends on PKCdelta/PKCepsilon functional couple 106
Germline PTPN11 mutation affecting exon 8 in a case of syndromic juvenile myelomonocytic leukemia 105
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma 105
T Cell Responses in Fungal Infections 104
[T-cell depletion today: pros and cons] 104
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 103
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils. 103
Trascriptome Analysis of Bone Marrow CD14+ Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance 102
Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation 101
Allogeneic transplants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. GITMO. Gruppo Italiano Trapianto di Midollo Osseo. 100
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in myeloma-induced angiogenesis and bone destruction in vitro and in vivo 100
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 100
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 99
Mieloma multioplo ed altre discrasie linfoplasmacellulari 99
T-cell depletion in allogeneic bone marrow transplantation for acute leukaemias. 99
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 99
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. 99
[Diffuse bone metastases, prevalently blastic, of adenocarcinoma of the colon] 98
Jack of all trades: thymosin α1 and its pleiotropy 98
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 97
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 97
Totale 12.689
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021822 0 0 0 0 0 25 27 19 438 46 244 23
2021/20221.512 19 15 17 64 45 28 170 257 62 197 85 553
2022/20235.299 688 350 244 381 463 586 60 352 1.913 35 165 62
2023/20241.800 128 230 53 60 155 515 68 116 25 68 144 238
2024/20256.419 62 398 520 413 640 424 182 367 838 627 605 1.343
2025/20268.055 1.107 1.277 1.810 1.038 2.185 638 0 0 0 0 0 0
Totale 31.243